Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene Citrate in Idiopathic Oligoasthenozoospermia
NCT06564961Phase 3Completed
- Start
- Jul 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oligoasthenozoospermia (OA) comparing Clomiphene Citrate with Placebo (2 arms). Primary endpoints: Change from baseline in sperm motility at 12 weeks and Change from baseline in sperm count at 12 weeks. Started Jul 2022; status: completed.
02
Drugs
clomiphene
03
Conditions
oligoasthenozoospermia (OA)
Beyond the preview
Go deeper on NCT06564961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06564961.